Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 2,84 € (-8,68 %). Medianen er 2,62 € (-15,76 %).

Køb
  3
Behold
  9
Sælg
  3

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Cronos Group hits 52-week high after strong Q2 results

    The Cronos Group share rose to a 52-week high of $3.44, with a market capitalization of $1.25 billion and year-to-date performance of 25.86%. InvestingPro points to an overvaluation versus fair value. Cronos beat expectations in Q2 2026 with revenue of $53 million (expectation $44.73 million), adjusted EPS of $0.09 (expectation $0.01), gross profit of $28.5 million and adjusted EBITDA of $13.1 million; cash and investments amounted to $827 million, and $60 million in share buybacks were reported. » Mere på de.investing.com


  • Cronos shares rise after Q2 results significantly beat expectations

    Cronos reported Q2 EPS of $0.09 (consensus $0.01) and revenue of $53.0 million versus expected $44.73 million. The company reported record net revenue, gross profit and adjusted EBITDA, organic revenue growth of 51% and record sales in Israel, Canada and Germany. Cronos repurchased a total of 12.3 million shares in H1 2026. The strong company-specific metrics pushed the stock sharply higher in pre-market trading and brought it closer to its 52-week high. » Mere på de.investing.com


  • Cronos Group names ATB Capital Markets as broker for share buyback program

    Cronos Group has appointed ATB Capital Markets Corp. (ATB Cormark) as broker for share repurchases on the Toronto Stock Exchange and other Canadian trading systems, replacing Virtu Canada Corp. The company gave no details on the reasons, size or timing of the buyback program. Cronos has most recently pursued an aggressive buyback strategy, which coincided with a 49% share price increase last year; market capitalization is around USD 1.04 billion. » Mere på de.investing.com


  • Cronos Group well above Q1 2026 forecasts; shares rise premarket

    Cronos Group reported Q1 2026 EPS of $0.04 (expectation $0.02) and revenue of CAD 45.2 million, up 40% year over year. Gross profit rose to CAD 19.2 million, adjusted EBITDA to CAD 5.1 million, and the balance sheet remains debt-free. Growth was driven mainly by stronger sales in Canada and Israel. After the results, the stock climbed about 9.45% in premarket trading. » Mere på de.investing.com


  • Cronos to release results for quarter ended 31 March 2026 on 11 May 2026

    Cronos will publish results for the quarter ended 31 March 2026 on 11 May 2026. Two analysts expect earnings per share of an average of 0.005 USD, after 0.030 CAD in the year‑ago quarter. Three analysts see revenue in the report at about 42.2 million USD versus 46.3 million CAD a year earlier. Four analysts expect, on average, earnings per share of 0.060 USD and revenue of about 191.2 million USD for the current fiscal year (prior year 204.8 million CAD). » Mere på finanzen.net

Virksomhedstal

I det seneste kvartal havde Cronos en omsætning på 56,02 mio. € og et nettoresultat på 12,19 mio. €
(EUR) september 2026
YoY
Omsætning 56,02 mio. 80,90 %
Bruttofortjeneste 28,5 mio. 82,45 %
Nettoresultat 12,19 mio. 44,90 %
EBITDA 16,85 mio. 35,26 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
1,14 mia. €
Antal aktier
366,47 mio.
Højeste/laveste i 52 uger
3,53 € - 2,06 €
Udbytte Nej
Beta
1,20
P/E (PE Ratio)
21,52
PEG (PEG Ratio)
-0,01
K/I (PB Ratio)
1,19
P/S (PS Ratio)
6,15

Virksomhedsprofil

Cronos Group Inc. driver virksomhed inden for cannabinoider. Virksomheden fremstiller, markedsfører og distribuerer kosttilskud og kosmetiske produkter baseret på hamp gennem e-handel, detailhandel og partnerkanaler inden for hotel- og restaurationsbranchen under mærkerne Lord Jones og Happy Dance i USA. Virksomheden er også involveret i dyrkning, fremstilling og markedsføring af cannabis og cannabisbaserede produkter til de medicinske markeder og markedet for voksne forbrugere. Den sælger cannabis og cannabisprodukter, herunder tørret cannabis, færdigrullede joints, spiselige produkter, koncentrater og cannabisekstrakter, gennem engros- og direkte kanaler til kunder under sin wellness-platform PEACE NATURALS, og driver mærker til voksne forbrugere, Spinach. Den eksporterer også tørret cannabis og cannabisolier til Tyskland, Israel og Australien. Cronos Group Inc. blev grundlagt i 2012 og har hovedkontor i Toronto, Canada.

Navn
Cronos
CEO
Michael Ryan Gorenstein
Hjemsted Stayner, on
Canada
Websted
Sektor
Sundhed
Branche
Sundhedsudbydere og -tjenester
Børsnotering
27.02.2018
Medarbejdere 610

Tickersymboler

Børs Symbol
NASDAQ
CRON
Toronto Stock Exchange
CRON.TO
Frankfurt
7CI.F
Düsseldorf
7CI.DU
München
7CI.MU
🍪

Parqet  bruger cookies. Læs mere